Bookmark and Share

Last Minute: "Furious holidaymakers finally get to Majorca after 43-hour flight delay - ITV News" Mon, 27 Jun 2022 08:27:24 GMT    "Stories of children killed in the Troubles to be told to MPs - The Guardian" Mon, 27 Jun 2022 07:00:00 GMT    "Birmingham explosion: Woman found dead and man seriously hurt - BBC" Mon, 27 Jun 2022 10:10:17 GMT    "'Dangerous' and violent man jailed for 'most appalling campaign of abuse' court had ever seen - Sky News" Mon, 27 Jun 2022 06:23:58 GMT    "Russia faces oil price cap in fresh blow to Kremlin - live updates - The Telegraph" Mon, 27 Jun 2022 10:49:53 GMT    "Liz Truss: we have a duty to fix the problems of the Northern Ireland protocol - Financial Times" Sun, 26 Jun 2022 11:00:59 GMT   "Zelenskiy meets G7 leaders as US plans to give air defence system to Ukraine - The Guardian" Mon, 27 Jun 2022 10:23:00 GMT    "Russia set for first debt default since 1998 as payment deadline passes - Financial Times" Mon, 27 Jun 2022 10:37:16 GMT    "Boris Johnson news ? live: PM insists he is ?not worried? by Tory leadership plots - The Independent" Mon, 27 Jun 2022 10:52:48 GMT    "Barristers walk out of courts in strike over pay - BBC" Mon, 27 Jun 2022 10:35:12 GMT      For more news, click here.

Remember me? 

Fall of
--0.39 (+0.99%) Gilead Sciences - [Ticker: GILD]Chart Gilead Sciences  News Gilead Sciences  Download Historical Prices for Metastock Gilead Sciences and Others  Technical Analysis Gilead Sciences  
Last Trade71.55Last Trade Time2018-12-03 - 00:00:00
Variation--0.39 (+0.99%)Open72.74
Volume2,159,096Average Volume (3m)0
YieldBid / Ask74.80 x 800 - 74.82 x 1,000
Former Close71.9452 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Gilead Sciences -  [Ticker: GILD] chart
Change to Gilead Sciences Interactive Technical Analysis Chart

Last 10 Forum Topics about Gilead Sciences:
No topics about Gilead Sciences [GILD] have been found, but a search on the Forum for more topics related to Gilead Sciences is advised.

 News about Gilead Sciences [GILD]:   (ordered by relevance)
  1. Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing  Gilead Sciences
  2. Gilead names new manufacturing head in wake of recent hiccups  FiercePharma
  3. Gilead Pharmaceutical Development, Manufacturing Exec Yang to Retire >GILD  MarketWatch
2022-06-27 | NDAQ:GILD | Press Release | Gilead Sciences Inc.  Stockhouse Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress? 2022  Gilead Sciences Gilead Sciences: Buy The Dip (NASDAQ:GILD)  Seeking Alpha Westminster Drug Project and Gilead Sciences join forces to take on hepatitis C  PharmaTimes All Magrolimab Studies Re-Opening for Enrollment in US | Gilead  Gilead Sciences Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV  Gilead Sciences Treatment With Hepcludex® (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks  Gilead Sciences CSRWire - Gilead Sciences Inaugural Data Science Symposium Gilead Stock: Future In Three Molecules (NASDAQ:GILD)  Seeking Alpha Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity  Gilead Sciences Do Traders Think Gilead Sciences, Inc. (GILD) Can Keep Climbing Wednesday?  InvestorsObserver Gilead wins suit over patient assistance program's 'colossal financial fraud'  STAT Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Raised by CAPROCK Group Inc.  Defense World Takeda Pharmaceutical Vs. Gilead Sciences: Which Stock Is The Dividend King?  Seeking Alpha Gilead Sciences is a Finalist for the PinkNews Awards in the Business Equality Category  Yahoo Finance Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Goldman Sachs Global Healthcare Conference (Transcript)  Seeking Alpha Gilead: CAR-T future is both auto and allo - Bioprocess Insider  BioProcess Insider Gilead Sciences, Inc. (GILD) Management presents at Bernstein 38th Annual Strategic Decisions Conference - Transcript  Seeking Alpha Gilead Breast-Cancer Drug Delays Progression by 1.5 Months  Bloomberg Gilead Sciences, Inc. (GILD) Management Presents at Jefferies Global Healthcare Conference - (Transcript)  Seeking Alpha Gilead Sciences Inc. stock falls Thursday, underperforms market  MarketWatch Gilead Sciences goes ex-dividend tomorrow  Seeking Alpha Gilead launches domestic products to local market  Hurriyet Daily News HGH Biosimilars Consumption Market Size And Forecast to 2028 |Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma ? Designer Women  Designer Women Providing Support for Women with Breast Cancer  Gilead Sciences ASCO: Can Gilead, Pfizer and AZ-Daiichi change breast cancer?  FiercePharma GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION  Yahoo Finance Bristol Myers' Breyanzi wins broader FDA approval to challenge Gilead's CAR-T  FiercePharma Gilead Sciences (GILD) Stock Moves -0.72%: What You Should Know  Nasdaq ViiV, Gilead and Janssen notch top scores with HIV/AIDS groups  FiercePharma Atrial Fibrillation Drugs Market Size, Scope and Forecast | ARCA Biopharma, Baxter International Inc., Bristol-Myers Squibb, Gilead Sciences, HUYA Biosciences, Janssen Pharmaceuticals, Pfizer Inc., Pierre Fabre, Servier, Xention Ltd. ? Designer Women  Designer Women Gilead Sciences expands regional footprint with new Dubai office  ZAWYA Red Biotechnology Market Size, Scope and Forecast | Amgen Inc., F. Hoffmann-La Roche, Gilead Sciences Inc., CSL, Pfizer Inc. ? Designer Women  Designer Women Veriti Management LLC Has $897000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)  Defense World Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of ?Hold? by Brokerages  Defense World PD-1 And PD-L1 Inhibitors Market Size, Scope and Forecast | Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene ? Designer Women  Designer Women Gilead Joining the Global Access to Oncology Medicines Coalition  Yahoo Finance Head to Head Contrast: Surrozen (NASDAQ:SRZN) vs. Gilead Sciences (NASDAQ:GILD)  Defense World Anti-Infective Drugs Market Size, Scope and Forecast | Gilead Sciences GlaxoSmithKline plc, Pfizer Novartis AG, Merck, Bayer AG, Others. ? Designer Women  Designer Women 2 Beaten-Down Dividend Stocks That Are Now Yielding 5%  The Motley Fool Gene Therapy Market Size, Scope and Forecast | Novartis AG, Biogen, Gilead Sciences MolMed SpA, Spark Therapeutics Orchard Therapeutics plc., SIBIONO, Bluebird bio Shanghai Sunway Biotech Co. Ltd., Human Stem Cells Institute. ? Designer Women  Designer Women HIV Vaccines Market Size, Scope and Forecast | VIIV healthcare, Gilead Sciences, Inc, GlaxoSmithKline plc, Merck Sharp & Dohme Corp., AbbVie Inc, Mylan NV, and many more. ? Designer Women  Designer Women Chemical Medication in COVID-19 Market is Thriving worldwide by 2029| Top Key Players Gilead Sciences, AbbVie, Johnson and Johnson ? Designer Women  Designer Women Compensated Cirrhosis Type C Market Research With Gilead Sciences, AbbVie, Novartis International, Intercept Pharmaceuticals, Novo Nordisk A/S | 2022 Report ? Indian Defence News  Indian Defence News 7 Biotech Stocks With Key Catalysts Coming in July  InvestorPlace Gilead Sciences Announces First Quarter 2022 Financial Results  Gilead Sciences Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results  Gilead Sciences 3 Top Dividend Stocks for Generating Passive Income  The Motley Fool Hypertension Drug Market Size, Share, SWOT Analysis, Growth & Forecast by 2030  Digital Journal Cerium Oxide Nanoparticles Market Incredible Possibilities, Growth with Industry Study, Detailed Analysis and Forecast ? Designer Women  Designer Women Gilead Sciences to Release First Quarter 2022 Financial Results on Thursday, April 28, 2022  Gilead Sciences X-Ray Devices and Accessories Market by 2029 | Abbvie Inc., Gilead Sciences Inc., Merck and Co. ? Indian Defence News  Indian Defence News Gilead Sciences to Present at Upcoming Investor Conferences  Gilead Sciences Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend  Gilead Sciences Small Molecule Sterile Injectable Drugs Market Research With Gilead Sciences, Inc., BIOCRYST PHARMACEUTICALS | Outlook, Growth By Top Companies, Regions, Trends and Forecasts by 2022 to 2026 ? Indian Defence News  Indian Defence News Cystic Fibrosis Therapeutics Market Size, Status, Recent Trends and Future Scope Analysis to 2027- Vertex Pharmaceuticals, F. Hoffmann-La Roche ? Designer Women  Designer Women Global Dental Vacuum Pumps Market Global Opportunity Analysis |Industry Forecast 2022-2029 | Pfizer, Gilead Sciences, Johnson & Johnson ? Designer Women  Designer Women Gilead Receives Complete Response Letter From US FDA for Investigational Lenacapavir Due to Vial Compatibility Issues  Gilead Sciences Systemic Scleroderma Treatment Market Insights, Forecast to 2030| Boehringer Ingelheim International GmbH, Novartis AG, Gilead Sciences Inc.  Digital Journal Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report  Gilead Sciences Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere  Gilead Sciences Liposome Drug Delivery Market Size 2022 -2029 | Gilead Sciences, Novartis, Pacira, Johnson & Johnson ? Indian Defence News  Indian Defence News Global Inflammatory Bowel Disease Treatment Industry to 2028 ? Key Drivers, Challenges and Trends by Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc, Alkem Laboratories Limited ? Designer Women  Designer Women Roche challenges CAR-T with bispecific blood cancer approval  FiercePharma Parkinsons Disease Drugs Consumption Market Size And Forecast to 2028 |Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma ? Designer Women  Designer Women Liver Diseases Therapeutics Market will generate new growth opportunities 2022-2028 | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, Glaxosmithkline Plc, F. Hoffmann-La Roche Ltd  Digital Journal Antifungal Drugs Market Size, Scope and Forecast | Astellas Pharma Inc., Kramer Laboratories, Pfizer Inc., GlaxoSmithKline plc., Gilead Sciences Basilea Pharmaceutica Ltd. ? Designer Women  Designer Women Adoptive Cell Therapy Market to See Booming at a CAGR of 21.5% by 2030 Future Scope with Novartis AG, Gilead Sciences, Castle Creek Biosciences, Lineage Cell Therapeutics  Medgadget Liver Diseases Therapeutics Market Size, Scope and Forecast | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Novartis AG, Alnylam Pharmaceuticals Protagonist Therapeuti  Designer Women Global Cancer Treatment Drugs Market 2022 Latest Innovations ? Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen ? Designer Women  Designer Women FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV  Gilead Sciences Global HIV Diagnosis Industry to 2028 ? Key Drivers, Challenges and Trends by Alere Inc., Abbott Healthcare, Abbvie Inc., Bristol-Myers Squibb, Janssen Therapeutics ? Designer Women  Designer Women Zika Vaccines Market Size, Scope and Forecast | Inovio Pharmaceuticals Emergent BioSolutions Inc., Gilead Sciences Inc., Precigen LUMOS PHARMA, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Bharat Biotec  Designer Women Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis and Industry Forecast 2022-2029 | GENFIT SA, Gilead Sciences, AstraZeneca, Novartis AG ? Designer Women  Designer Women Gilead Statement on WHO Recommendation of Veklury® (Remdesivir) and Acceleration of Prequalification Submission  Gilead Sciences Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation  Gilead Sciences Gilead Announces Global Resolution of Bictegravir Patent Dispute with ViiV Healthcare  Gilead Sciences Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting  Gilead Sciences AstraZeneca launches first COVID drug DTC ad with Evusheld  FiercePharma Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?  The Motley Fool Gilead Sciences opens new drug development hub in Dublin  PharmaTimes Kite Receives US FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland  Gilead Sciences Respiratory Syncytial Virus Rsv Diagnostics Market 2022 New Tech Developments ?| Roche, Gilead Sciences, AbbVie ? Indian Defence News  Indian Defence News Huge demand of Warts Therapeutics Market by 2029 | Gilead Sciences, Inc., Sanofi ? Indian Defence News  Indian Defence News On HIV Testing Day in Louisiana, stigma remains obstacle to testing to reduce disease rate  The Advocate Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters  FiercePharma Veklury® (Remdesivir) Retains Antiviral Activity Against Omicron, Delta and Other Emergent SARS-CoV-2 Variants in Multiple In Vitro Studies  Gilead Sciences Gilead to Expand Footprint in Oceanside  Gilead Sciences Sterile Injections Compounding Pharmacy Market Sales Statistics, Future Growth, Emerging Trends to 2032 | Johnson & Johnson Merck & Co., GlaxoSmithKline, Gilead Sciences ? Indian Defence News  Indian Defence News Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs  Gilead Sciences 2 Red Flags for Gilead Sciences' Future  The Motley Fool Antiviral Therapy Drug Market Size, Development, Key Opportunity, Application & Forecast to 2030 ? Designer Women  Designer Women FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies  Gilead Sciences Gilead Sciences states COVID antiviral Veklury performs better the earlier its administered  FiercePharma Providing Health and Wellness Support for Women in Chicago ESG Goals | Gilead  Gilead Sciences Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study  Medscape Gilead Implements Contract Pharmacy Integrity Initiative for Branded Hepatitis C Products  Gilead Sciences Gilead Sciences joins the ABPI  The Association of the British Pharmaceutical Industry
For more news about Gilead Sciences click here:
Gilead Sciences News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources